Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Zimner-Rapuch

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
SAGE Open Medicine|January 28, 2025
Experiences and overall impact reported by people living with obesity: results from a multinational studyEsther Artime, Swarna Khare, Sarah Zimner-Rapuch, et al.
Advances in Therapy|March 13, 2026
Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled TrialsAndreea Ciudin, Helene Sapin, Ludi Fan, et al.
Annals of Internal Medicine|June 23, 2025
Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to TirzepatideBruno Linetzky, Naveed Sattar, Subodh Verma, et al.
Advances in Therapy|August 1, 2025
Clinical and Humanistic Burden of Adult Obesity in Asia-Pacific: A Systematic Literature ReviewEsther Artime, Sarah Zimner-Rapuch, Roger Chen, et al.
Diabetes, Obesity & Metabolism|June 20, 2025
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetesAndreea Ciudin, Erin Johansson, Sarah Zimner-Rapuch, et al.
Advances in Therapy|August 19, 2025
Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O StudyEsther Artime, Erik Spaepen, Sarah Zimner-Rapuch, et al.
JAMA Internal Medicine|November 24, 2025
Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 TrialDeborah B Horn, Bruno Linetzky, Melanie J Davies, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
SAGE Open Medicine|January 28, 2025
Experiences and overall impact reported by people living with obesity: results from a multinational studyEsther Artime, Swarna Khare, Sarah Zimner-Rapuch, et al.
Advances in Therapy|March 13, 2026
Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled TrialsAndreea Ciudin, Helene Sapin, Ludi Fan, et al.
Annals of Internal Medicine|June 23, 2025
Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to TirzepatideBruno Linetzky, Naveed Sattar, Subodh Verma, et al.
Advances in Therapy|August 1, 2025
Clinical and Humanistic Burden of Adult Obesity in Asia-Pacific: A Systematic Literature ReviewEsther Artime, Sarah Zimner-Rapuch, Roger Chen, et al.
Diabetes, Obesity & Metabolism|June 20, 2025
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetesAndreea Ciudin, Erin Johansson, Sarah Zimner-Rapuch, et al.
Advances in Therapy|August 19, 2025
Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O StudyEsther Artime, Erik Spaepen, Sarah Zimner-Rapuch, et al.
JAMA Internal Medicine|November 24, 2025
Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 TrialDeborah B Horn, Bruno Linetzky, Melanie J Davies, et al.
Pageof 2